Aerovate Therapeutics
AVTE
#8977
Rank
NZ$99.15 M
Marketcap
$3.43
Share price
1.67%
Change (1 day)
-84.49%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$27.95 M

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are NZ$27.95 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$13.47 M213.45%
2021-12-31NZ$4.3 M-82.87%
2020-12-31NZ$25.1 M136.67%
2019-12-31NZ$10.6 M